7h
Diabetes advocates cross their fingers as a bipartisan bill revives efforts to lower insulin costs
A bipartisan group of senators is aiming to relieve that cost burden with the INSULIN Act , a bill to cap the cost of the ...
Senators are pushing the bipartisan INSULIN Act of 2026, which would cap insulin costs at $35 a month for insured and ...
Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.
A bipartisan quartet of of senators on Wednesday unveiled legislation to cap the monthly cost of insulin at $35 for patients ...
The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...
A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...
For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug ...
Bipartisan senators unveil a $35 insulin cap for many privately insured people and a 10-state pilot for the uninsured.
GlobalData on MSN
Novo Nordisk receives FDA approval for basal insulin Awiqli
The FDA’s decision is based on data from the ONWARDS Phase IIIa clinical programme involving nearly 2,680 adults.
Denisha Roberson is now racing to replace insulin for her 10-year-old, who has Type 1 diabetes, along with medicated creams ...
The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results